ORIC vs RVMD
ORIC: ORIC Pharmaceuticals is a clinical-stage oncology company developing targeted therapies for hard-to-treat cancers through precision medicine approaches. RVMD: Revolution Medicines is a precision oncology company developing targeted therapies to treat RAS-addicted cancers through its proprietary research platform.
Side-by-side fundamentals
| Metric | ORIC | RVMD | Edge |
|---|---|---|---|
| Price as of 2026-08-06 close | $12.93 | $197.81 | |
| Market cap as of 2026-08-08 | $1.3B | $42.4B | |
| PEG as of 2026-08-08 | n/a | -0.23 | |
| Net margin as of 2026-08-08 | n/a | -2833.9% | |
| Operating margin as of 2026-08-08 | n/a | -3145.0% | |
| ROE as of 2026-08-08 | -35.4% | -54.1% | ORIC higher |
| ROA as of 2026-08-08 | -33.4% | -39.1% | ORIC higher |
| Debt / equity as of 2026-08-08 | 0.00 | 0.19 | ORIC lower |
| Beta as of 2026-08-08 | 0.95 | 1.40 | |
| 1-year return as of 2026-08-06 close | +30.9% | +439.4% | RVMD higher |
Fundamentals: market data, as of 2026-08-08. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-06.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.